The launch of the first NCB4 laboratory in Spain, located in Tres Cantos (Madrid), represents a significant step in the field of biosafety and scientific research. These types of facilities are designed to work with high-risk biological agents.
NCB4 laboratories require highly advanced containment systems, strict protocols and highly specialised personnel. Their function is key to the study of emerging pathogens and to strengthening the capacity to respond to health crises.
This advance is set against a global backdrop in which biosecurity has assumed growing importance. Having infrastructure of this calibre enables improved surveillance, research and preparedness against biological risks.
Sources consulted
AEBIOS:
Opening of the first NCB4 laboratory in Spain
GSK Spain:
Tres Cantos R&D Centre